Form F-1/A - Registration statement for certain foreign private issuers: [Amend]
SEC Accession No. 0001615774-18-001079
Filing Date
2018-02-13
Accepted
2018-02-13 09:25:39
Documents
9

Document Format Files

Seq Description Document Type Size
1 F-1/A s109025_f1a.htm F-1/A 2479479
2 EXHIBIT 23.1 s109025_ex23-1.htm EX-23.1 2386
3 GRAPHIC s109025_pg3.jpg GRAPHIC 17469
4 GRAPHIC s109025_pg5.jpg GRAPHIC 61242
5 GRAPHIC s109025_pg82.jpg GRAPHIC 169885
6 GRAPHIC s109025_pg89.jpg GRAPHIC 53898
7 GRAPHIC s109025_pg90.jpg GRAPHIC 42605
8 GRAPHIC s109025_pg91.jpg GRAPHIC 43036
9 GRAPHIC s109025_pg92.jpg GRAPHIC 25637
  Complete submission text file 0001615774-18-001079.txt   3053689
Mailing Address HEMMELRATHER WEG 201 LEVERKUSEN 2M D-51377
Business Address HEMMELRATHER WEG 201 LEVERKUSEN 2M D-51377 011 49 214 876 00
Biofrontera AG (Filer) CIK: 0001712641 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: F-1/A | Act: 33 | File No.: 333-222546 | Film No.: 18599425
SIC: 2834 Pharmaceutical Preparations